These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 8856474)
1. Tranilast restores cytokine-induced nitric oxide production against platelet-derived growth factor in vascular smooth muscle cells. Hishikawa K; Nakaki T; Hirahashi J; Marumo T; Saruta T J Cardiovasc Pharmacol; 1996 Aug; 28(2):200-7. PubMed ID: 8856474 [TBL] [Abstract][Full Text] [Related]
2. Tranilast inhibits the effects of platelet-derived growth factor on cell proliferation and induction of nitric oxide. Hishikawa K; Nakaki T; Hirahashi J; Marumo T; Saruta T Eur J Pharmacol; 1995 Nov; 291(3):435-8. PubMed ID: 8719431 [TBL] [Abstract][Full Text] [Related]
3. Antiproliferative and c-myc mRNA suppressive effect of tranilast on newborn human vascular smooth muscle cells in culture. Miyazawa K; Hamano S; Ujiie A Br J Pharmacol; 1996 Jun; 118(4):915-22. PubMed ID: 8799562 [TBL] [Abstract][Full Text] [Related]
4. Antiproliferative effect of L-NAME on rat vascular smooth muscle cells. El Mabrouk M; Singh A; Touyz RM; Schiffrin EL Life Sci; 2000 Aug; 67(13):1613-23. PubMed ID: 10983855 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory mechanism of tranilast in human coronary artery smooth muscle cells proliferation, due to blockade of PDGF-BB-receptors. Watanabe S; Matsuda A; Suzuki Y; Kondo K; Ikeda Y; Hashimoto H; Umemura K Br J Pharmacol; 2000 May; 130(2):307-14. PubMed ID: 10807667 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of PDGF- and TGF-beta 1-induced collagen synthesis, migration and proliferation by tranilast in vascular smooth muscle cells from spontaneously hypertensive rats. Miyazawa K; Kikuchi S; Fukuyama J; Hamano S; Ujiie A Atherosclerosis; 1995 Dec; 118(2):213-21. PubMed ID: 8770315 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of tranilast on expression of transforming growth factor-beta isoforms and receptors in injured arteries. Ward MR; Sasahara T; Agrotis A; Dilley RJ; Jennings GL; Bobik A Atherosclerosis; 1998 Apr; 137(2):267-75. PubMed ID: 9622270 [TBL] [Abstract][Full Text] [Related]
8. Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Effects on cell proliferation. Scott-Burden T; Schini VB; Elizondo E; Junquero DC; Vanhoutte PM Circ Res; 1992 Nov; 71(5):1088-100. PubMed ID: 1327576 [TBL] [Abstract][Full Text] [Related]
9. Blockade of DNA synthesis induced by platelet-derived growth factor by tranilast, an inhibitor of calcium entry, in vascular smooth muscle cells. Nie L; Mogami H; Kanzaki M; Shibata H; Kojima I Mol Pharmacol; 1996 Oct; 50(4):763-9. PubMed ID: 8863820 [TBL] [Abstract][Full Text] [Related]
10. Tranilast inhibits the growth of rat mesangial cells. Ikeda M; Ikeda U; Shimada K; Fujita N; Okada K; Saito T; Minota S; Kano S Eur J Pharmacol; 1997 Apr; 324(2-3):283-7. PubMed ID: 9145784 [TBL] [Abstract][Full Text] [Related]
11. The anti-platelet agent, ticlopidine, upregulates interleukin-1-Beta-stimulated nitric oxide production in cultured rat vascular smooth muscle cells. Inoue M; Kusano E; Ito C; Akimoto T; Iimura O; Nemoto J; Amemiya M; Muto S; Asano Y Exp Nephrol; 2002; 10(4):267-74. PubMed ID: 12097830 [TBL] [Abstract][Full Text] [Related]
12. Tranilast inhibits vascular smooth muscle cell growth and intimal hyperplasia by induction of p21(waf1/cip1/sdi1) and p53. Takahashi A; Taniguchi T; Ishikawa Y; Yokoyama M Circ Res; 1999 Mar; 84(5):543-50. PubMed ID: 10082476 [TBL] [Abstract][Full Text] [Related]
13. Tranilast suppresses intimal hyperplasia in the balloon injury model and cuff treatment model in rabbits. Fukuyama J; Ichikawa K; Miyazawa K; Hamano S; Shibata N; Ujiie A Jpn J Pharmacol; 1996 Apr; 70(4):321-7. PubMed ID: 8774760 [TBL] [Abstract][Full Text] [Related]